Evidence map›Paper›PMID 30476138›Full record

ArticleHuman molecular genetics2019

Sequence variants associating with urinary biomarkers.

Stefania Benonisdottir, Ragnar P Kristjansson, Asmundur Oddsson, Valgerdur Steinthorsdottir, Evgenia Mikaelsdottir, Birte Kehr, Brynjar O Jensson, Gudny A Arnadottir, Gerald Sulem, Gardar Sveinbjornsson and 28 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. WDR72 Is Required for Urinary Acidification and Normal HActa physiologica (Oxford, England) · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Phenotypic Spectrum ofKidney international reports · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Stefania BenonisdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ragnar P KristjanssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Asmundur OddssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Valgerdur SteinthorsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Evgenia MikaelsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Birte KehrBerlin Institute of Health (BIH), Berlin, Germany.
Brynjar O JenssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gudny A ArnadottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gerald SulemdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gardar SveinbjornssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Snaedis KristmundsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Erna V IvarsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Vinicius TragantedeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Bjarni GunnarssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Hrafnhildur Linnet RunolfsdottirFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Joseph G ArthurdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Aimee M DeatondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gudmundur I EyjolfssonIcelandic Medical Center (Laeknasetrid), Laboratory in Mjodd (RAM), Reykjavik, Iceland.
Olafur B DavidssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Folkert W AsselbergsDepartment of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
Astradur B HreidarssonDivision of Endocrinology and Metabolic Medicine, Internal Medicine Services, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Thorunn RafnardeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gudmar ThorleifssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Vidar EdvardssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Gunnar SigurdssonDivision of Endocrinology and Metabolic Medicine, Internal Medicine Services, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Anna HelgadottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Bjarni V HalldorssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gisli MassondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Hilma HolmdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Pall T OnundarsonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Olafur S IndridasonDivision of Nephrology, Internal Medicine Services, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Rafn BenediktssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Runolfur PalssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Daniel F GudbjartssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Isleifur OlafssonDepartment of Clinical Biochemistry, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Patrick SulemdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Kari StefanssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urine dipstick tests are widely used in routine medical care to diagnose kidney and urinary tract and metabolic diseases. Several environmental factors are known to affect the test results, whereas the effects of genetic diversity are largely unknown. We tested 32.5 million sequence variants for association with urinary biomarkers in a set of 150 274 Icelanders with urine dipstick measurements. We detected 20 association signals, of which 14 are novel, associating with at least one of five clinical entities defined by the urine dipstick: glucosuria, ketonuria, proteinuria, hematuria and urine pH. These include three independent glucosuria variants at SLC5A2, the gene encoding the sodium-dependent glucose transporter (SGLT2), a protein targeted pharmacologically to increase urinary glucose excretion in the treatment of diabetes. Two variants associating with proteinuria are in LRP2 and CUBN, encoding the co-transporters megalin and cubilin, respectively, that mediate proximal tubule protein uptake. One of the hematuria-associated variants is a rare, previously unreported 2.5 kb exonic deletion in COL4A3. Of the four signals associated with urine pH, we note that the pH-increasing alleles of two variants (POU2AF1, WDR72) associate significantly with increased risk of kidney stones. Our results reveal that genetic factors affect variability in urinary biomarkers, in both a disease dependent and independent context.

Indexed as

AdultAgedAllelesBiomarkersFemaleGenetic VariationHematuriaHumansHydrogen-Ion ConcentrationIcelandKetosisKidneyMaleMiddle AgedProteinuriaSodium-Glucose Transporter 2BiomarkersSLC5A2 protein, humanSodium-Glucose Transporter 2

Identifiers

PMID30476138
PMCPMC6423415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.